Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity
Clinical trial NCT06315972 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06315972
- Sponsor
- LMU Klinikum
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2026-11-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.